In vitro modelling of respiratory infections in idiopathic pulmonary fibrosis (IPF) using human induced pluripotent stem cell (hiPSCs)-derived alveolar epithelial type II cells

QR Code

In vitro modelling of respiratory infections in idiopathic pulmonary fibrosis (IPF) using human induced pluripotent stem cell (hiPSCs)-derived alveolar epithelial type II cells

Idiopathic pulmonary fibrosis (IPF) is a chronic, interstitial lung disease estimated to affect 4.5 individuals per 10,000[1]. It is characterised by the accumulation of extracellular matrix in the lung interstitium, which disrupts the normal architecture and impairs lung function resulting in sever...

Full description

Bibliographic Details
Main Author:	Serna Valverde, Ana Lilia
Format:	Thesis (University of Nottingham only)
Language:	English
Published:	2023
Subjects:	Idiopathic pulmonary fibrosis; In vitro model; Alveolar type 2 cells; Infection modelling; Human induced pluripotent stem cells
Online Access:	https://eprints.nottingham.ac.uk/76715/

Similar Items

Development of a human induced pluripotent stem cells (hiPSCs)-derived, universal platform, for generation of immunocompetent multi-tissue organoids
by: Azis, Rizal
Published: (2024)

Developing a chemically defined, xeno-free platform to differentiate human induced pluripotent stem cells to type 2 alveolar epithelial cells of the lung
by: Reed, Liam
Published: (2024)

Directed differentiation of human induced pluripotent stem cells into functional cholangiocyte-like cells
by: Sampaziotis, Fotios, et al.
Published: (2017)

Generation of mouse induced pluripotent stem cells using polycistronic lentiviral vector in feeder - and serum-free culture
by: Mahmaud, Akram Faisal
Published: (2015)

Modelling non-alcoholic fatty liver disease (NAFLD) using human induced pluripotent stem cell (hiPSC)-derived hepatocytes
by: Lo, Peggy Cho Kiu
Published: (2022)

Effects of hypoxia and hyperoxia on the differential expression of VEGF-A isoforms and receptors in Idiopathic Pulmonary Fibrosis (IPF)
by: Barratt, Shaney L., et al.
Published: (2018)

Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review
by: Hutchinson, John P., et al.
Published: (2015)

Using human induced pluripotent stem cells to study the in vitro phenotype of the cardiac channelopathies
by: Duncan, Gary
Published: (2017)

Developing a model system to investigate the epigenetic mechanisms underlying pluripotency in human cells
by: Matsa, Elena
Published: (2010)

Evaluation of activity limitation in patients with idiopathic pulmonary fibrosis grouped according to Medical Research Council Dyspnea Grade
by: Kozu, R., et al.
Published: (2014)

Drug-mediated shortening of action potentials in LQTS2 hiPSC-cardiomyocytes
by: Duncan, Gary, et al.
Published: (2017)

An investigation into the function and mechanism of a GRK5-L41 polymorphism using human pluripotent cell-derived cardiomyocytes
by: Vo, Nguyen T. N.
Published: (2021)

Increasing global mortality from idiopathic pulmonary fibrosis in the twenty-first century
by: Hutchinson, John P., et al.
Published: (2014)

The role of Interleukin-33 in the development of idiopathic pulmonary fibrosis
by: Stephenson, Katherine
Published: (2021)

Materials for stem cell factories of the future
by: Celiz, Adam D., et al.
Published: (2014)

Investigating pluripotency and primordial germ cell development in axolotl with a focus on axnanog and axblimp1
by: Redwood, Catherine
Published: (2009)

Human pluripotent stem cells derived-cardiomyocytes (hPSC-CMs) to assess the impact of drug- and gene-induced changes on cell function
by: Mohd Yusof, Nurul Ain Nasim
Published: (2020)

Evaluating human induced pluripotent stem cell-derived cardiomyocytes for commercial drug testing
by: Katili, Puspita Anggraini
Published: (2020)

Investigations into novel small molecules as potential treatments for idiopathic pulmonary fibrosis and malaria
by: Park, Jozef
Published: (2022)

Investigating heparan sulphate in development using human pluripotent stem cells
by: Thompson, Jamie
Published: (2022)

Establishment of the human cardiac models using gene editing and reprogramming in Human Pluripotent Stem Cells to understand the putative functions of the G-protein coupled receptor kinase 5 polymorphism (GRK5-L41)
by: Hoang, Minh Duc
Published: (2017)

Preparation of potent and selective αvβ6 integrin inhibitors for the treatment of idiopathic pulmonary fibrosis and synthetic approaches towards the total synthesis of mescengricin
by: Robinson, Henry Duncan
Published: (2021)

Gene expression network analysis of the routes to pluripotency
by: Amaral, Fabio M R
Published: (2018)

Discovery of a novel polymer for human pluripotent stem cell expansion and multilineage differentiation
by: Celiz, Adam D., et al.
Published: (2015)

Current status of drug screening and disease modelling in human pluripotent stem cells
by: Rajamohan, Divya, et al.
Published: (2013)

Induced pluripotent stem cells from human hair follicle keratinocytes as a potential source for in vitro hair follicle cloning
by: Lim, Sheng Jye, et al.
Published: (2016)

Automation and scale-up of human induced pluripotent stem cell models of cardiovascular disease for drug screening
by: Crutchley, James E.B.
Published: (2016)

Simplified footprint-free Cas9/CRISPR editing of cardiac-associated genes in human pluripotent stem cells
by: Kondrashov, Alexander, et al.
Published: (2018)

Probing the role of organic cation transporters in respiratory epithelial cell proliferation in vitro
by: Shemiss, Ligia
Published: (2016)

Conserved principles of the pluripotency and primordial germ cell gene regulatory networks: from basal vertebrates to mammals
by: Simpson, Luke Alexander
Published: (2022)

Development of multiparametric kinetic data and analytics workflows for the generation of an hiPSC-cardiomyocyte based cardiovascular model
by: Raniga, Kavita
Published: (2024)

The role of galectin-3 in the development of idiopathic pulmonary fibrosis
by: Parmar, Nimesh
Published: (2019)

Targeting HOXA in engineered iPSCs and pre-clinical leukaemia models
by: Abuhantash, Mays
Published: (2023)

Role of TWEAK in coregulating liver progenitor cell and fibrogenic responses
by: Tirnitz-Parker, Nina, et al.
Published: (2014)

Can human pluripotent stem cell-derived cardiomyocytes advance understanding of muscular dystrophies?
by: Kalra, Spandan, et al.
Published: (2016)

Disease modeling hypertrophic cardiomyopathy using CRISPR/Cas9 genome editing technology in human pluripotent stem cell-derived cardiomyocytes
by: Mosqueira, Diogo
Published: (2018)

CRISPR/Cas9 editing in human pluripotent stem cell-cardiomyocytes highlights arrhythmias, hypocontractility, and energy depletion as potential therapeutic targets for hypertrophic cardiomyopathy
by: Mosqueira, Diogo, et al.
Published: (2018)

Evaluation of minicircle-induced pluripotent stem cell
by: Daneshvar, Nasibeh
Published: (2014)

Canine idiopathic chronic hepatitis
by: Bexfield, Nicholas
Published: (2017)

Linking molecular targets to hypertrophic cardiomyopathy using genome-edited human induced pluripotent stem cell cardiomyocytes
by: Bodbin, S.E.
Published: (2022)